CLSI EP26-Ed2-IG

User Evaluation of Acceptability of a Reagent Lot Change Implementation Guide, EP26-Ed2-IG

Clinical and Laboratory Standards Institute, 11/01/2022

Publisher: CLSI

File Format: PDF

$25.00$50.00


Published:01/11/2022

Pages:14

File Size:1 file , 920 KB

Note:This product is unavailable in Russia, Belarus

This implementation guide describes the minimum procedures necessary for a medical laboratory to verify that new reagent lots, when received and implemented by the laboratory, will produce results consistent with previous reagent lots. Reagent lot performance is validated by the developer before release and distribution; however, the laboratory needs to verify each new reagent lot it receives. Changes in performance with a new reagent lot could be due to:
• Changes in reagent component materials
• Instability of a component in a reagent
• Reagents that were compromised in transportation or storage
• Incorrect calibration of the new reagent lot

Verifying that these potential changes have not occurred is important to ensure the quality of laboratory results. For additional information on the acceptability of a reagent lot change, see CLSI document EP26.1

More CLSI standard pdf

CLSI I/LA21-A2

CLSI I/LA21-A2

Clinical Evaluation of Immunoassays; Approved Guideline--Second Edition, ILA21A2E

$90.00 $180.00

CLSI C54-A-IR

CLSI C54-A-IR

Verification of Comparability of Patient Results Within One Health Care System; Approved Guideline

$105.00 $210.92

CLSI POCT02-A

CLSI POCT02-A

Implementation Guide of POCT01 for Health Care Providers; Approved Guideline, POCT02AE

$142.00 $285.24

CLSI M48-A

CLSI M48-A

Laboratory Detection and Identification of Mycobacteria; Approved Guideline, M48AE

$90.00 $180.00